Clincosm LogoSign in Get a demo

waldenström macroglobulinemia

Showing 1 - 25 of 154
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B-cell Malignancies Undergoing Treatment With Bruton Tyrosine

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • +4 more
  • Non-Interventional Study
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Nov 22, 2023

Waldenstrom Macroglobulinemia Trial in Napoli

Completed
  • Waldenstrom Macroglobulinemia
    • Napoli, Italy
      University of Naples "Federico II" Naples, Italy, 80100 Contact:
    Oct 10, 2023

    Waldenstrom Macroglobulinemia, Waldenstrom's Macroglobulinemia Recurrent, Waldenstrom's Macroglobulinemia Refractory Trial

    Not yet recruiting
    • Waldenstrom Macroglobulinemia
    • +2 more
    • (no location specified)
    Jul 18, 2023

    Waldenstrom Macroglobulinemia Trial in Tianjin (Zanubrutinib, Bendamustine and Rituximab)

    Recruiting
    • Waldenstrom Macroglobulinemia
    • Zanubrutinib, Bendamustine and Rituximab
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Jun 13, 2023

    Waldenstrom Macroglobulinemia, B-Cell Lymphoproliferative Disorder Trial in Boston (Pirtobrutinib, Venetoclax, Allopurinol)

    Not yet recruiting
    • Waldenstrom Macroglobulinemia
    • B-Cell Lymphoproliferative Disorder
    • Boston, Massachusetts
    • +2 more
    Feb 18, 2023

    Waldenstrom Macroglobulinemia Trial in Japan (Ibrutinib, Rituximab)

    Active, not recruiting
    Has Results
    • Waldenstrom Macroglobulinemia
    • Chiba, Japan
    • +8 more
    Jan 27, 2023

    Waldenstrom Macroglobulinemia Trial in China (Ibrutinib)

    Active, not recruiting
    • Waldenstrom Macroglobulinemia
    • Changchun, China
    • +5 more
    Jan 27, 2023

    Clinical, Laboratory and Epidemiologic Characterization of

    Recruiting
    • Waldenstrom Macroglobulinemia
    • +4 more
      • Bethesda, Maryland
      • +1 more
      Jan 25, 2023

      Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia

      Active, not recruiting
      • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +36 more
      • Buffalo, New York
        Roswell Park Cancer Institute
      Jan 23, 2023

      B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma Trial in Australia, United States (BGB-16673)

      Recruiting
      • B-cell Malignancy
      • +8 more
      • Phoenix, Arizona
      • +14 more
      Jan 17, 2023

      Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in United States (Zilovertamab vedotin)

      Active, not recruiting
      • Chronic Lymphocytic Leukemia
      • +11 more
      • Zilovertamab vedotin
      • Duarte, California
      • +13 more
      Jan 12, 2023

      Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-cell Marginal Zone, Lymphoma, Non-Hodgkin Trial in Worldwide (LOXO-338,

      Active, not recruiting
      • Leukemia, Lymphocytic, Chronic, B-Cell
      • +6 more
      • Duarte, California
      • +8 more
      Jan 11, 2023

      Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,

      Active, not recruiting
      • Adult Grade III Lymphomatoid Granulomatosis
      • +23 more
      • autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
      • +2 more
      • Duarte, California
        City of Hope Medical Center
      Jan 4, 2023

      Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Worldwide (Iopofosine I 131 single dose,

      Recruiting
      • Waldenstrom Macroglobulinemia
      • +8 more
      • Iopofosine I 131 single dose
      • +2 more
      • Redlands, California
      • +42 more
      Dec 30, 2022

      Waldenstrom Macroglobulinemia Trial (Zanubrutinib)

      Not yet recruiting
      • Waldenstrom Macroglobulinemia
      • (no location specified)
      Nov 28, 2022

      Mantle Cell Lymphoma, Peripheral T-cell Lymphoma (PTCL), Cutaneous T-cell Lymphoma (CTCL) Trial in Augusta, Nashville, Houston

      Recruiting
      • Mantle Cell Lymphoma
      • +9 more
      • L-Bcl-2 antisense oligonucleotide
      • Augusta, Georgia
      • +2 more
      Nov 18, 2022

      IgM MGUS, Waldenstrom Macroglobulinemia, Neuropathy;Peripheral Trial in Boston (Acalabrutinib, Rituximab)

      Recruiting
      • IgM MGUS
      • +2 more
      • Boston, Massachusetts
      • +1 more
      Nov 14, 2022

      Waldenstrom Macroglobulinemia Trial in Canada (Acalabrutinib, Bendamustine, Rituximab)

      Recruiting
      • Waldenstrom Macroglobulinemia
      • Calgary, Alberta, Canada
      • +8 more
      Nov 9, 2022

      Waldenstrom Macroglobulinemia Trial (Venetoclax; Rituximab, DRC)

      Not yet recruiting
      • Waldenstrom Macroglobulinemia
      • Venetoclax; Rituximab
      • DRC
      • (no location specified)
      Nov 4, 2022

      MRD and Clonal Evolution in Waldenström's Macroglobulinemia and

      Active, not recruiting
      • Waldenstrom Macroglobulinemia
      • MRD and clonal evolution
      • Milano, MI, Italy
      • +13 more
      Nov 2, 2022

      B-cell Malignancy, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (AS-1763)

      Not yet recruiting
      • B-cell Malignancy
      • +7 more
      • (no location specified)
      Oct 26, 2022

      Waldenstrom Macroglobulinemia Trial in United States (Umbralisib)

      Completed
      • Waldenstrom Macroglobulinemia
      • Washington, District of Columbia
      • +3 more
      Oct 19, 2022

      Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)

      Recruiting
      • Adenocarcinoma
      • +75 more
      • Biomarker Testing (L)
      • +2 more
      • Idaho Falls, Idaho
      • +1 more
      Oct 18, 2022

      Mature B-Cell Tumor, Non Hodgkin Lymphoma, DLBCL Trial (SGR-1505)

      Not yet recruiting
      • Mature B-Cell Neoplasm
      • +25 more
      • (no location specified)
      Sep 14, 2022

      Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Lymphocytic, Small, Lymphoma, Mantle-Cell Trial in Worldwide (Pirtobrutinib)

      Available
      • Leukemia, Lymphocytic, Chronic, B-Cell
      • +4 more
      • Stanford, California
      • +61 more
      Aug 17, 2022